Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment-Reference-Cited by-同舟云学术

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Published:2021-04 Issue:4 Volume:24 Page:102367
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Ohashi Hirofumi,Watashi Koichi,Saso Wakana,Shionoya Kaho,Iwanami Shoya^ORCID,Hirokawa Takatsugu^ORCID,Shirai Tsuyoshi,Kanaya Shigehiko,Ito Yusuke^ORCID,Kim Kwang Su,Nomura Takao,Suzuki Tateki,Nishioka Kazane,Ando Shuji,Ejima Keisuke^ORCID,Koizumi Yoshiki^ORCID,Tanaka Tomohiro,Aoki Shin,Kuramochi Kouji^ORCID,Suzuki Tadaki,Hashiguchi Takao,Maenaka Katsumi^ORCID,Matano Tetsuro^ORCID,Muramatsu Masamichi,Saijo Masayuki,Aihara Kazuyuki,Iwami Shingo,Takeda Makoto,McKeating Jane A.,Wakita Takaji

Funder

JST

Japan Society for the Promotion of Science

Wellcome Trust

AMED

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference49 articles.

1. Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity;Akpovwa;Cell Biochem. Funct.,2016

2. Cepharanthine: an update of its mode of action, pharmacological properties and medical applications;Bailly;Phytomedicine,2019